| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/06/2004 | US6673570 Smad associating polypeptides |
| 01/06/2004 | US6673569 Dsb protein family, includes dsba (formation of) and dsbc (isomerizing of) disulfide bonds, and dsbb or dsbd to control the reactivity of dsba/dsbc; use to study coexpression effects of these proteins in secretion of a foreign protein |
| 01/06/2004 | US6673561 Use in monitoring the treatment of blood disorders in a patient by monitoring changes in the levels of fibrinopeptide b (fpb) in the patient's urine |
| 01/06/2004 | US6673559 Met proto-oncogene and a method for predicting breast cancer progression |
| 01/06/2004 | US6673540 Cell systems having specific interaction of peptide binding pairs |
| 01/06/2004 | US6673535 Nucleic acid sequences; hybridization probes; primers; oligonucleotides; used in the detection and diagnosis of degenerative neurological disorders of the nervous system |
| 01/06/2004 | US6673534 Methods for detection of mutations in myostatin variants |
| 01/06/2004 | US6673370 Oxidized collagen formulations for use with non-compatible pharmaceutical agents |
| 01/06/2004 | US6673356 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 01/06/2004 | US6673355 Administering vaccine to pregnant women; prevention and diagnosis of gastroenteritis, cystic fibrosis, and diarrhea |
| 01/06/2004 | US6673354 Compositions and methods for treating papillomavirus-infected cells |
| 01/06/2004 | US6673353 Tuberculosis vaccine |
| 01/06/2004 | US6673351 Immunotherapeutic agent comprising purified protein extract derived from killed cells of amastigotes and leishmania |
| 01/06/2004 | US6673349 Crosslinking; forming vaccines |
| 01/06/2004 | US6673348 Heat shock protein-based vaccines and immunotherapies |
| 01/06/2004 | US6673347 Conjugated to polymer via schiff base, hydrazone, oxime, or azomethine compound; diagnosing tumors and metastasis |
| 01/06/2004 | US6673346 Compositions and methods for the treatment of sepsis |
| 01/06/2004 | US6673344 Antibodies to human CKβ-10/MCP-4 |
| 01/06/2004 | US6673343 Useful for activating their respective receptor and thereby enabling the role of tyrosine kinase receptor in cell growth and/or differentiation to be studied |
| 01/06/2004 | US6673341 Inhibiting transforming growth factor (tgf-beta) mediated angiogenesis, thereby inhibiting the proliferative disease in vertebrate |
| 01/06/2004 | CA2142712C Bordetella bronchiseptica vaccine |
| 01/06/2004 | CA2135083C Antibodies to p-selectin and their uses |
| 01/06/2004 | CA2134094C Production of recombinant human lactoferrin |
| 01/06/2004 | CA2128208C Novel seven transmembrane receptors |
| 01/06/2004 | CA2096109C Tissue factor based prothrombin time reagent |
| 01/06/2004 | CA2086681C Growth promoting agent derived from milk |
| 01/06/2004 | CA2047721C Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma |
| 01/02/2004 | EP1376136A2 Assay for the determination of the hormonal effect of compounds |
| 01/02/2004 | EP1376132A1 G protein-coupled receptor structural model and a method of designing ligand binding to g protein-coupled receptor by using the structural model |
| 01/02/2004 | EP1375670A1 Recombinant measles viruses expressing epitopes of antigens of RNA viruses and use of the recombinant viruses for the preparation of vaccine compositions |
| 01/02/2004 | EP1375667A1 Rice-origin high expression polypeptide chain elongation factor promoter and method of using the same |
| 01/02/2004 | EP1375664A1 Method for the sectetion and production of protein |
| 01/02/2004 | EP1375663A1 Novel protein, dna thereof and use of the same |
| 01/02/2004 | EP1375662A1 A novel polypeptide compose substance for promoting blood and blood vessel cell growth |
| 01/02/2004 | EP1375658A1 Novel clock gene promoter |
| 01/02/2004 | EP1375654A2 Transgenic and cloned mammals |
| 01/02/2004 | EP1375648A1 Methods for detecting and adjusting replication of hepatitis b virus and for preparing mutated virus strains with altered replication efficiency |
| 01/02/2004 | EP1375520A1 Apoptosis induced by monoclonal antibody anti-Her2 |
| 01/02/2004 | EP1375518A1 Anti-osteopontin antibody and use thereof |
| 01/02/2004 | EP1375517A1 Structure of a glucocorticoid receptor ligand binding domain comprising an expanded binding pocket and methods employing same |
| 01/02/2004 | EP1375516A2 Method of production of a recombinant polypeptide of the LSR receptor |
| 01/02/2004 | EP1375515A2 Polypeptide, cDNA encoding the same, and use thereof |
| 01/02/2004 | EP1375514A2 5'ESTs for secreted proteins expressed in various tissues |
| 01/02/2004 | EP1375513A1 Immunopotentiators |
| 01/02/2004 | EP1375512A1 Infectious cDNA of an approved vaccine strain of measles virus. Use for immunogenic compositions |
| 01/02/2004 | EP1375511A2 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
| 01/02/2004 | EP1375510A1 Modification of collagenous materials and medical treatment, diagnosis and monitoring of fibrotic conditions |
| 01/02/2004 | EP1374910A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 01/02/2004 | EP1374909A2 Evaluation of, delivery of, and use of agents to treat heart disorders |
| 01/02/2004 | EP1374891A1 Method for accelerating the rate of mucociliary clearance |
| 01/02/2004 | EP1374888A1 Remedies for arthritis deformans and remedies for rheumatoid arthritis |
| 01/02/2004 | EP1374672A1 Drosophila strain carrying bradeion gene(s) transferred thereinto |
| 01/02/2004 | EP1373905A2 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents |
| 01/02/2004 | EP1373904A1 Method for promoting aggregate formation from protein subunits |
| 01/02/2004 | EP1373890A2 Means for the identification of compounds capable of inhibiting karap-transduced signals |
| 01/02/2004 | EP1373887A1 Computer-based strategy for peptide and protein conformational ensemble enumeration and ligand affinity analysis |
| 01/02/2004 | EP1373886A2 Thermodynamic propensities of amino acids in the native state ensemble: implications for fold recognition |
| 01/02/2004 | EP1373576A2 Nucleic acids and methods for detecting viral infection, uncovering anti-viral drug candidates and determining drug resistance of viral isolates |
| 01/02/2004 | EP1373571A2 Functional surface display of polypeptides |
| 01/02/2004 | EP1373568A2 Gene for identifying individuals with familial dysautonomia |
| 01/02/2004 | EP1373564A2 Diagnosis of illnesses or predisposition to certain illnesses |
| 01/02/2004 | EP1373546A1 Carrier chimeric proteins, targeted carrier chimeric proteins and preparation thereof |
| 01/02/2004 | EP1373545A2 Mch1r deficient mice |
| 01/02/2004 | EP1373541A2 Process for the production of l-amino acids using strains of the family enterobacteriaceae that contain an attenuated frur gene |
| 01/02/2004 | EP1373540A1 Polysubstituted polycarboxylic phosphoamide biopolymers, methods for their production and uses of compositions derived therefrom |
| 01/02/2004 | EP1373536A2 Lentiviral packaging constructs |
| 01/02/2004 | EP1373534A2 Production of genetically modified plants with puroindolines |
| 01/02/2004 | EP1373532A1 Gene encoding plant protein tm2a, conferring resistance to tomato mosaic virus |
| 01/02/2004 | EP1373530A2 Protein kinase stress-related proteins and methods of use in plants |
| 01/02/2004 | EP1373529A1 Tau-opathy model |
| 01/02/2004 | EP1373526A2 Therapeutic polypeptides, nucleic acids encoding same, and methodes of use |
| 01/02/2004 | EP1373525A1 Gene-targeted animal model of apolipoprotein e4 domain interaction and uses thereof |
| 01/02/2004 | EP1373514A2 Phosphorylation modifications of apoptin |
| 01/02/2004 | EP1373513A2 Streptococcus pneumoniae proteins and nucleic acids |
| 01/02/2004 | EP1373512A1 Fragment of l. lactis plasmid conferring antiphage activity and uses thereof |
| 01/02/2004 | EP1373511A2 Genes and proteins, and their uses |
| 01/02/2004 | EP1373510A2 Mutant allergens |
| 01/02/2004 | EP1373508A2 Human cytokine receptor |
| 01/02/2004 | EP1373507A2 Stress-responsive activator of p300 (strap) protein |
| 01/02/2004 | EP1373506A2 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter |
| 01/02/2004 | EP1373505A2 Tri-hybrid melanoma antigen |
| 01/02/2004 | EP1373504A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 01/02/2004 | EP1373503A2 Neurotrophic factors |
| 01/02/2004 | EP1373502A2 Dopaminergic neuronal survival-promoting factors and uses thereof |
| 01/02/2004 | EP1373501A2 Targeting molecules for adenoviral vectors |
| 01/02/2004 | EP1373500A2 Gene involved in v(d)j recombination and/or dna repair |
| 01/02/2004 | EP1373499A2 Hin-1, a tumor suppressor gene |
| 01/02/2004 | EP1373496A1 Methods for identifying peptides which modulate a biological process |
| 01/02/2004 | EP1373493A1 Coagulation factor vii derivatives |
| 01/02/2004 | EP1373485A2 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby |
| 01/02/2004 | EP1373479A1 Methods for monitoring prothease inhibitor antiretroviral therapy |
| 01/02/2004 | EP1373478A1 Attenuated live vaccine |
| 01/02/2004 | EP1373477A2 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
| 01/02/2004 | EP1373471A2 Defined culture medium |
| 01/02/2004 | EP1373470A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 01/02/2004 | EP1373319A2 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373314A2 Human arginine-rich protein-related compositions |